X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
prostate cancer (203) 203
index medicus (177) 177
male (177) 177
humans (175) 175
castrate-resistant prostate cancer (124) 124
oncology (124) 124
docetaxel (82) 82
chemotherapy (76) 76
metastasis (74) 74
castrate resistant prostate cancer (73) 73
urology & nephrology (70) 70
aged (64) 64
androgen receptor (61) 61
cancer (61) 61
prostatic neoplasms - drug therapy (57) 57
survival (55) 55
middle aged (54) 54
prostatic neoplasms - pathology (54) 54
abiraterone (50) 50
prostatic neoplasms, castration-resistant - drug therapy (50) 50
metastatic castrate-resistant prostate cancer (47) 47
prostatic neoplasms, castration-resistant - pathology (44) 44
antineoplastic agents - therapeutic use (42) 42
castrate-resistant (42) 42
abiraterone acetate (40) 40
androgens (40) 40
aged, 80 and over (39) 39
castrate resistant (38) 38
urology (38) 38
enzalutamide (36) 36
mitoxantrone (36) 36
care and treatment (35) 35
expression (35) 35
prostate (34) 34
mitoxantrone plus prednisone (33) 33
treatment outcome (33) 33
animals (32) 32
immunotherapy (31) 31
disease progression (30) 30
men (30) 30
orchiectomy (30) 30
prognosis (30) 30
increased survival (29) 29
neoplasm metastasis (29) 29
castration (28) 28
prednisone (28) 28
research (28) 28
cell line, tumor (27) 27
pharmacology & pharmacy (27) 27
urologic and male genital diseases (27) 27
prostatic neoplasms - metabolism (26) 26
receptors, androgen - metabolism (26) 26
therapy (26) 26
cabazitaxel (23) 23
taxoids - therapeutic use (23) 23
androgen antagonists - therapeutic use (22) 22
antineoplastic combined chemotherapy protocols - therapeutic use (22) 22
bone metastases (22) 22
cancer therapies (22) 22
patients (22) 22
bone neoplasms - secondary (21) 21
development and progression (21) 21
neoplasms. tumors. oncology. including cancer and carcinogens (21) 21
sipuleucel-t (21) 21
cells (20) 20
metastases (20) 20
prostatic neoplasms - surgery (20) 20
prostatic neoplasms - therapy (20) 20
analysis (19) 19
prostatic neoplasms, castration-resistant - mortality (19) 19
review (19) 19
endocrinology & metabolism (18) 18
clinical trials (17) 17
double-blind (17) 17
medicine & public health (17) 17
cell biology (16) 16
drug resistance, neoplasm (16) 16
growth (16) 16
progression (16) 16
prostate-specific antigen - blood (16) 16
prostatic neoplasms, castration-resistant - metabolism (16) 16
quality of life (16) 16
tumors (16) 16
castrate‐resistant prostate cancer (15) 15
clinical trials as topic (15) 15
phenylthiohydantoin - analogs & derivatives (15) 15
plus prednisone (15) 15
prostate-specific antigen (15) 15
prostatic neoplasms, castration-resistant - genetics (15) 15
radium-223 (15) 15
retrospective studies (15) 15
testosterone (15) 15
androgen deprivation therapy (14) 14
antineoplastic agents, hormonal - therapeutic use (14) 14
antitumor-activity (14) 14
biomarkers (14) 14
disease-free survival (14) 14
drug therapy (14) 14
management (14) 14
metastatic castrate resistant prostate cancer (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2015, Volume 67, Issue 3, pp. 470 - 479
Journal Article
Journal of carcinogenesis, ISSN 1477-3163, 2011, Volume 10, Issue 1, pp. 20 - 20
.... Prostate cancer initiation and progression is also uniquely dependent on AR. Androgen deprivation therapy remains the standard of care for treatment of advanced prostate cancer... 
Androgen receptor; castrate-resistant prostate cancer; signaling
Journal Article
Neoplasia, ISSN 1476-5586, 08/2019, Volume 21, Issue 8, pp. 802 - 809
Journal Article
Cell (Cambridge), ISSN 0092-8674, 2018, Volume 174, Issue 2, pp. 422 - 432.e13
Journal Article
Journal Article